White Papers

Measuring Partner Impact and CRM ROI Across the Enterprise white paper banner

Quantifying Connection: Measuring Partner Impact and CRM ROI Across the Enterprise

Discover the measurable value of CRM with our new white paper: Quantifying Connection—Measuring Partner Impact and CRM ROI Across the Enterprise. This publication highlights how our Patient Services Omnichannel CRM delivers measurable improvements in operational efficiency, patient outcomes, and industry best practices. The white paper provides evidence-based insights addressing a central challenge in specialty therapy […]

Quantifying Connection: Measuring Partner Impact and CRM ROI Across the Enterprise Read More »

White paper: Reimagining Patient Support ROI with AI

From Barriers to Breakthroughs: Reimagining Patient Support ROI with AI

Discover Breakthroughs in Patient Support ROI Struggling with complex patient journeys and mounting workloads? See how Claritas Rx is helping organizations reduce manual tasks by 23,000 hours each year, allowing teams to focus on what matters most: improving patient access. Download our new white paper, “From Barriers to Breakthroughs: Reimagining Patient Support ROI with AI,”

From Barriers to Breakthroughs: Reimagining Patient Support ROI with AI Read More »

white paper available: One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains

One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains

Accelerating market access data delivery from multi-day lags to next-day reporting enables earlier patient interventions, reduces therapy abandonment, and can potentially deliver over $241K in measurable revenue gains in one month. A single-day improvement in data availability supported faster therapy starts for hundreds of patients, prevented drop-offs, and freed teams to focus on strategic initiatives

One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains Read More »

Claritas Rx Offers Four Strategies to Mitigate Specialty Treatment Abandonment

From Prescription to Abandonment—Why 31% of Specialty Medications Go Unfilled

This Claritas Rx  white paper analyzes over 85,000 specialty prescriptions to reveal the key reasons for prescription abandonment during pharmacy transitions, including administrative challenges, communication gaps, and insurance hurdles. What’s Inside: The real drivers of specialty medication abandonment The impact of pharmacy transitions on patient care Four proven strategies to reduce abandonment and improve outcomes

From Prescription to Abandonment—Why 31% of Specialty Medications Go Unfilled Read More »

Unlocking The Mystery: Patient Treatment Abandonment in Pharmaceuticals

Understanding Why Patients Abandon Prescribed Treatments

Download the White Paper Navigating the patient treatment journey is like solving a complex puzzle for the pharmaceutical industry. At every turn, there are challenges, most notably the phenomenon of patient treatment abandonment. Imagine spending years developing a drug that could potentially save thousands of lives, only to find out that a significant portion of

Understanding Why Patients Abandon Prescribed Treatments Read More »